Since 2001, Lilly has utilized Phase Forward’s InForm product in over 200 trials and plans to continue to use InForm for global trials across all phases, as well as mandating the use of the InForm product with its global service partners.
Jeffrey Kasher, vice president and COO of global clinical development at Eli Lilly, said: “We look forward to continuing to leverage Phase Forward as our clinical data management solution of choice.
“Phase Forward has been a longstanding member of Eli Lilly’s Alliance program and has been instrumental in providing Lilly with technology solutions in order to expand our global trials.”